Telehealth Cognitive Behavioral Therapy for Alcohol Abuse with Cardiovascular Risk

(ACME-TM Trial)

HD
DB
Overseen ByDaniel Blalock, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: VA Office of Research and Development
Must be taking: Hypertension, Hyperlipidemia, Diabetes
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new method to assist veterans who struggle with alcohol use and face heart disease risks, such as high blood pressure or diabetes. It combines online therapy sessions with daily text messages to reduce alcohol use and improve heart health. This approach, known as Alcohol and CVD Management and Engagement through Telehealth and mHealth (ACME-TM), provides support through telehealth cognitive behavioral therapy. Participants must have alcohol-related issues and heart risk factors, like uncontrolled high blood pressure, and must own a phone capable of receiving text messages. The goal is to determine if these methods are user-friendly and beneficial for both veterans and their doctors. As an unphased trial, this study offers veterans the chance to explore innovative support methods that could enhance their health and well-being.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, you must be on an appropriate medication regimen for cardiovascular disease prevention, which will be reviewed by a research coordinator and a doctor.

What prior data suggests that this intervention is safe for alcohol misuse and cardiovascular risk?

Research shows that telehealth cognitive behavioral therapy (CBT) for alcohol misuse is generally safe. Studies have found that digital CBT can help people stop drinking without causing serious harm.

Safety information specifically about telehealth indicates that serious problems are rare. However, not all studies reported detailed information about any issues, so while problems are uncommon, they might not be fully documented.

Overall, telehealth treatments, including CBT, appear to be well-tolerated. Participants in these studies did not report major negative effects, suggesting the treatment is safe for most people, though individual experiences might differ. Discussing any concerns with the clinical team is always advisable.12345

Why are researchers excited about this trial?

Researchers are excited about the ACME-TM treatment because it combines telehealth cognitive behavioral therapy (CBT) with daily mobile health (mHealth) support to tackle both alcohol misuse and cardiovascular risk. Unlike traditional face-to-face therapy sessions and medication, this approach leverages technology to provide accessible, real-time support, making it easier for participants to integrate into their daily lives. The addition of daily text messages for a month also offers continuous engagement and motivation, which is a novel way to help reduce cardiovascular risk factors alongside alcohol use. This dual-focus and tech-driven delivery method could represent a significant advancement in treating these conditions concurrently.

What evidence suggests that this telehealth CBT is effective for alcohol misuse and cardiovascular risk?

Research has shown that online therapy, known as telehealth cognitive behavioral therapy (CBT), can effectively help people struggling with alcohol misuse. In this trial, participants will receive the ACME-TM treatment, which includes telehealth CBT sessions focused on reducing alcohol misuse. Studies have found that telehealth CBT makes it easier for people to access the help they need and has shown promise in reducing alcohol consumption. Combining telehealth with text messages can also encourage healthier habits, which may help manage heart health risks. This method might particularly benefit people with high blood pressure, as reducing alcohol intake can help lower blood pressure. While research is ongoing, early results suggest that this approach could reduce alcohol misuse and improve heart health.16789

Who Is on the Research Team?

DB

Daniel Blalock, PhD

Principal Investigator

Durham VA Medical Center, Durham, NC

Are You a Good Fit for This Trial?

This trial is for Veterans with uncontrolled high blood pressure, hyperlipidemia, or diabetes who misuse alcohol. They must be enrolled in specific VA clinics, have a history of these conditions for at least a year, take medication for them, and have access to text messaging. Excluded are those in other CVD or alcohol treatment trials, with severe alcohol dependence or significant withdrawal symptoms.

Inclusion Criteria

Self-reported access to any SMS text-capable phone.
My medication for heart disease prevention has been approved by the research team.
Enrolled in 1 of 3 primary care clinics associated with the Durham VAHCS, as evidenced by at least one outpatient PCP visit recorded in Managerial Cost Accounting (MCA) system.
See 4 more

Exclusion Criteria

I don't have any upcoming surgeries or need major changes to my medications.
I am currently receiving palliative care or am in a nursing/hospice home.
EHR AUDIT-C suggestive of severe alcohol dependence requiring medical treatment, defined as 10-12 for both men and women.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive 4 sessions of telehealth cognitive behavioral therapy (CBT) focused on reducing alcohol misuse, followed by a 5th telehealth coaching call to develop a plan for cardiovascular risk factors. Participants then receive daily texts for one month aimed at helping them decrease these cardiovascular risk factors.

6 weeks
5 telehealth sessions, daily text messages for 4 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessments of treatment acceptability and SMS text acceptability.

10 weeks
Post-treatment assessments

Long-term Follow-up

Participants' systolic blood pressure and self-reported heavy drinking days are monitored to assess long-term outcomes.

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Alcohol and CVD Management and Engagement through Telehealth and mHealth (ACME-TM)
Trial Overview The ACME-TM program combines cognitive-behavioral therapy via telehealth and mobile health technologies to reduce alcohol misuse and improve cardiovascular health behaviors among veterans. It includes personalized text messages and coaching calls focused on transitioning treatment targets.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: ACME-TMExperimental Treatment1 Intervention

Alcohol and CVD Management and Engagement through Telehealth and mHealth (ACME-TM) is already approved in United States for the following indications:

🇺🇸
Approved in United States as ACME-TM for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials
1,691
Recruited
3,759,000+

Published Research Related to This Trial

Cognitive Behaviour Therapy (CBT) is an effective psychological intervention for cardiovascular disease, focusing on preventing disease occurrence and addressing psychological impacts.
CBT can help modify behavioral risk factors like smoking and diet, as well as target psychological processes that contribute to heart disease, showing promise for improving patient outcomes.
Cognitive behaviour therapy for cardiovascular diseases.Johnston, DW.[2019]
Telehealth interventions (THI) significantly reduce the incidence of cardiovascular disease (CVD) in patients with a history of CVD, with a relative risk reduction of 45% compared to usual care, based on a meta-analysis of 8 randomized controlled trials involving 1635 individuals.
In contrast, THI did not show a significant effect on CVD incidence in patients without a prior history of CVD, indicating that the benefits of THI may be more pronounced in those already at risk.
Effect of telehealth interventions on major cardiovascular outcomes: a meta-analysis of randomized controlled trials.Gu, X., Zhu, Y., Zhang, Y., et al.[2020]
Telehealth interventions for patients with coronary heart disease (CHD) significantly reduced rehospitalization and cardiac events compared to usual care, indicating their effectiveness in secondary prevention.
While telehealth did not show a significant reduction in all-cause mortality compared to cardiac rehabilitation, it was associated with improvements in modifiable risk factors like cholesterol levels and smoking status, suggesting it can be a valuable alternative or addition to traditional rehabilitation programs.
Telehealth interventions for the secondary prevention of coronary heart disease: A systematic review and meta-analysis.Jin, K., Khonsari, S., Gallagher, R., et al.[2023]

Citations

Telehealth Treatment of Veterans With Alcohol Misuse at ...The primary objective of this project is to refine a cognitive-behavioral intervention for comorbid alcohol misuse and modifiable CVD risk with diverse ...
2.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/31209579/
Telehealth Treatment for Alcohol MisuseEvidence for telehealth cognitive behavioral therapy (CBT) is preliminary but suggests it is efficacious and increased access to treatment.
FY 2024 VA-Funded ProjectsIf you are a Veteran in crisis or concerned about one, connect with our caring, qualified responders for confidential help.
Integration of telehealth approaches across the alcohol ...Purpose of Review Telehealth interventions for alcohol misuse may be especially impactful in hypertensive populations because of the increased blood ...
Research Articles and PapersThis research examined the use of telehealth for behavioral health services at Critical Access Hospitals (CAHs). Findings indicate that patient ...
Transdiagnostic CBT for Comorbid Alcohol Use and ...In this clinical trial, the investigators will further assess the UP's effectiveness in reducing alcohol consumption in patients with comorbid AUD/AXD.
A Digital Cognitive Behavioral Therapy Program for Adults ...Participants assigned to digital CBT showed substantial increases in rates of abstinence from alcohol during a relatively brief treatment period ...
Virtual reality-assisted cognitive behavioral therapy for ...We demonstrated VR-CBT to be a feasible intervention for patients with AUD which supports continued investigations in a larger randomized clinical trial.
Evidence Brief: Safety and Effectiveness of Telehealth ... - NCBISerious harms associated with telehealth delivery appear to be rare, but adverse events were not consistently reported across studies. Only 2 studies examined ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security